Page last updated: 2024-08-17

medroxyprogesterone acetate and Hip Fractures

medroxyprogesterone acetate has been researched along with Hip Fractures in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	3 (42.86)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Anderson, GL; Aragaki, AK; Chlebowski, RT; Gass, M; Johnson, KC; Kuller, LH; Manson, JE; Prentice, RL; Rossouw, JE; Shadyab, AH; Stefanick, ML; Wactawski-Wende, J; Wallace, R	1
Aragaki, A; Carbone, L; Crandall, CJ; Jackson, R; Johnson, KC; Lewis, CE; Manson, JE; Robbins, JA; Sarto, G; Stefanick, ML; Wactawski-Wende, J	1
Anderson, G; Aragaki, AK; Beresford, SA; Cauley, JA; Chlebowski, RT; Eaton, CB; Gass, M; Howard, BV; Hsia, J; Jackson, RD; Johnson, KC; Kooperberg, C; Kuller, LH; LaCroix, AZ; Lewis, CE; Limacher, M; Liu, S; Manson, JE; Margolis, KL; Martin, LW; O'Sullivan, MJ; Ockene, JK; Powell, LH; Prentice, RL; Rossouw, JE; Simon, MS; Stefanick, ML; Thomson, CA; Van Horn, L; Vitolins, MZ; Wactawski-Wende, J; Wallace, RB; Wassertheil-Smoller, S	1
Aedo, S; Barriga, P; Blümel, JE; Brantes, S; Campodónico, Í; Cavada, G; Chedraui, P; Fica, J; Irribarra, C; Vallejo, M	1
Machens, K; Schmidt-Gollwitzer, K	1
Cooper, MH	1

Reviews

1 review(s) available for medroxyprogesterone acetate and Hip Fractures

Article	Year
Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma? Human reproduction (Oxford, England), 2003, Volume: 18, Issue:10 Topics: Biometry; Cardiovascular Diseases; Coronary Disease; Data Collection; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Hip Fractures; Humans; Medroxyprogesterone Acetate; Neoplasms; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Risk	2003

Article

Year

Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma?

Human reproduction (Oxford, England), 2003, Volume: 18, Issue:10

Topics: Biometry; Cardiovascular Diseases; Coronary Disease; Data Collection; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Hip Fractures; Humans; Medroxyprogesterone Acetate; Neoplasms; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Risk

2003

Trials

3 trial(s) available for medroxyprogesterone acetate and Hip Fractures

Article	Year
Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age. American journal of epidemiology, 2021, 02-01, Volume: 190, Issue:3 Topics: Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Postmenopause; Proportional Hazards Models; Pulmonary Embolism; Stroke	2021
Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:2 Topics: Aged; Bone Density; Calcium; Cholecalciferol; Dietary Supplements; Double-Blind Method; Drug Interactions; Drug Synergism; Estrogen Replacement Therapy; Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Prospective Studies; United States; Women's Health	2014
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA, 2013, Oct-02, Volume: 310, Issue:13 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Drug Therapy, Combination; Endometrial Neoplasms; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hip Fractures; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Pulmonary Embolism; Quality of Life; Risk; Stroke; Treatment Outcome; United States	2013

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Hip Fractures

Article	Year
Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks. Menopause (New York, N.Y.), 2015, Volume: 22, Issue:12 Topics: Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Monte Carlo Method; Placebos; Proportional Hazards Models; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Survival Rate; Women's Health	2015
Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study. Ginecologia y obstetricia de Mexico, 2002, Volume: 70 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hip Fractures; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Time Factors; Venous Thrombosis	2002
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause; Spinal Fractures	2004